Israel - English - Ministry of Health

teva pharmaceutical industries ltd, israel - acetylsalicylic acid - tablets enteric coated - acetylsalicylic acid 100 mg - acetylsalicylic acid - acetylsalicylic acid - the primary prevention of coronary heart disease in patients at increased risk and the secondary prevention of thrombotic cerebrovascular or cardiovascular disease.

Israel - English - Ministry of Health

teva pharmaceutical industries ltd, israel - verapamil hydrochloride - tablets slow release - verapamil hydrochloride 240 mg - verapamil - verapamil - mild to moderate hypertension. angina pectoris.

Israel - English - Ministry of Health

teva pharmaceutical industries ltd, israel - verapamil hydrochloride - tablets sustained release - verapamil hydrochloride 180 mg - verapamil - verapamil - mild to moderate hypertention. angina pectoris.

Israel - English - Ministry of Health

teva pharmaceutical industries ltd, israel - verapamil hydrochloride - tablets slow release - verapamil hydrochloride 240 mg - verapamil - mild to moderate hypertension. angina pectoris.

Israel - English - Ministry of Health

teva pharmaceutical industries ltd, israel - verapamil hydrochloride - tablets sustained release - verapamil hydrochloride 180 mg - verapamil - mild to moderate hypertention. angina pectoris.

Israel - English - Ministry of Health

teva pharmaceutical industries ltd, israel - venlafaxine as hydrochloride - capsules - venlafaxine as hydrochloride 75 mg - venlafaxine - venlafaxine - for the treatment of depression. maintenance of recurrent depression. generalized anxiety disorder (gad) - short term and long-term. social anxiety disorder (sad).

Israel - English - Ministry of Health

teva pharmaceutical industries ltd, israel - venlafaxine as hydrochloride - capsules - venlafaxine as hydrochloride 150 mg - venlafaxine - venlafaxine - for the treatment of depression. maintenance of recurrent depression. generalized anxiety disorder (gad) - short term and long-term. social anxiety disorder (sad).

Israel - English - Ministry of Health

eli lilly israel ltd, israel - atomoxetine - solution (oral) - atomoxetine 4 mg / 1 ml - atomoxetine - strattera is indicated for the treatment of attention-deficit/hyperactivity disorder (adhd) in children of 6 years and older, in adolescents and in adults as part of a comprehensive treatment programme. treatment must be initiated by a specialist in the treatment of adhd, such as a paediatrician, child/adolescent psychiatrist, or psychiatrist. diagnosis should be made according to current dsm criteria or the guidelines in icd.in adults, the presence of symptoms of adhd that were pre-existing in childhood should be confirmed. third-party corroboration is desirable and strattera should not be initiated when the verification of childhood adhd symptoms is uncertain. diagnosis cannot be made solely on the presence of one or more symptoms of adhd. based on clinical judgment, patients should have adhd of at least moderate severity as indicated by at least moderate functional impairment in 2 or more settings (for example, social, academic, and/or occupational functioning), affecting several aspects of an individual’s life.

Israel - English - Ministry of Health

unipharm ltd, israel - escitalopram as oxalate - tablets - escitalopram as oxalate 10 mg - escitalopram - escitalopram - treatment of depression and panic disorder. treatment of generalized anxiety disorder (gad), treatment of social anxiety disorder (social phobia).treatment of obsessive compulsive disorder.

Israel - English - Ministry of Health

unipharm ltd, israel - escitalopram as oxalate - tablets - escitalopram as oxalate 20 mg - escitalopram - escitalopram - treatment of depression and panic disorder. treatment of generalized anxiety disorder (gad), treatment of social anxiety disorder (social phobia).treatment of obsessive compulsive disorder.